Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-12 09:38 am Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | Adage Capital Management, L.P. | 3,485,931 3.280% | 3,485,931![]() (New Position) | Filing History |
2024-11-12 09:37 am Purchase | 2024-09-30 | 13G | Savara Inc. SVRA | Adage Capital Management, L.P. | 6,753,701 4.100% | 6,753,701![]() (New Position) | Filing History |
2024-11-12 09:37 am Purchase | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Adage Capital Management, L.P. | 528,937 4.390% | 528,937![]() (New Position) | Filing History |
2024-11-12 09:37 am Purchase | 2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL | Adage Capital Management, L.P. | 2,000,594 4.580% | 2,000,594![]() (New Position) | Filing History |
2024-11-12 09:36 am Purchase | 2024-09-30 | 13G | Perella Weinberg Partners PWP | Adage Capital Management, L.P. | 1,037,615 1.900% | 1,037,615![]() (New Position) | Filing History |
2024-11-12 09:36 am Purchase | 2024-09-30 | 13G | Amalgamated Financial Corp. AMAL | Adage Capital Management, L.P. | 716,262 2.340% | 716,262![]() (New Position) | Filing History |
2024-11-12 09:36 am Purchase | 2024-09-30 | 13G | Guild Holdings Company GHLD | Adage Capital Management, L.P. | 597,110 2.840% | 597,110![]() (New Position) | Filing History |
2024-11-12 09:35 am Unchanged | 2024-09-30 | 13G | Verastem, Inc. VSTM | Adage Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2024-11-12 09:35 am Purchase | 2024-09-30 | 13G | Rezolute, Inc. RZLT | Adage Capital Management, L.P. | 2,842,163 4.910% | 2,842,163![]() (New Position) | Filing History |
2024-11-12 09:35 am Purchase | 2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Adage Capital Management, L.P. | 854,083 4.810% | 854,083![]() (New Position) | Filing History |
2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Nkarta, Inc. NKTX | Adage Capital Management, L.P. | 3,600,000 5.100% | 3,600,000![]() (New Position) | Filing History |
2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Adage Capital Management, L.P. | 2,250,132 2.750% | 2,250,132![]() (New Position) | Filing History |
2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Veru Inc. VERU | Adage Capital Management, L.P. | 786,111 5.370% | 786,111![]() (New Position) | Filing History |
2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Adage Capital Management, L.P. | 3,634,475 7.430% | 3,634,475![]() (New Position) | Filing History |
2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | Adage Capital Management, L.P. | 9,703,351 6.660% | 9,703,351![]() (New Position) | Filing History |
2024-11-12 09:34 am Unchanged | 2024-09-30 | 13G | Vinci Partners Investments Ltd. VINP | Adage Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2024-11-12 09:33 am Sale | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 3,791,420 7.080% | -1,364,879![]() (-26.47%) | Filing History |
2024-11-12 09:33 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 3,322,146 8.550% | 3,322,146![]() (New Position) | Filing History |
2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | Aura Biosciences, Inc. AURA | Adage Capital Management, L.P. | 4,881,125 9.840% | 4,881,125![]() (New Position) | Filing History |
2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Adage Capital Management, L.P. | 369,097 9.990% | 369,097![]() (New Position) | Filing History |